As the relative burden of community-acquired bacterial pneumonia among HIV-positive patients increases, adequate prediction of case severity on presentation is crucial. We sought to determine what characteristics measurable on presentation are predictive of worse outcomes. We studied all admissions for community-acquired bacterial pneumonia over one year at a tertiary centre. Patient demographics, comorbidities, HIV-specific markers and CURB-65 scores on Emergency Department presentation were reviewed. Outcomes of interest included mortality, bacteraemia, intensive care unit admission and orotracheal intubation. A total of 396 patients were included: 49 HIV-positive and 347 HIVnegative. Mean CURB-65 score was 1.3 for HIV-positive and 2.2 for HIV-negative patients (p < 0.0001), its predictive value for mortality being maintained in both groups (p ¼ 0.03 and p < 0.001, respectively). Adjusting for CURB-65 scores, HIV infection by itself was only associated with bacteraemia (adjusted odds ratio [AOR] 7.1, 95% CI [2.6-19.5]). Patients with < 200 CD4 cells/mL presented similar CURB-65 adjusted mortality (aOR 1.7, 95% CI [0.2-15.2]), but higher risk of intensive care unit admission (aOR 5.7, 95% CI [1.5-22.0]) and orotracheal intubation (aOR 9.1, 95% CI [2.2-37.1]), compared to HIV-negative patients. These two associations were not observed in the > 200 CD4 cells/mL subgroup (aOR 2.2, 95% CI [0.7-7.6] and aOR 0.8, 95% CI [0.1-6.5], respectively). Antiretroviral therapy and viral load suppression were not associated with different outcomes (p > 0.05). High CURB-65 scores and CD4 counts < 200 cells/mL were both associated with worse outcomes. Severity assessment scales and CD4 counts may both be helpful in predicting severity in HIV-positive patients presenting with community-acquired bacterial pneumonia.
Introduction
Early since the introduction of highly active antiretroviral therapy (HAART) in the mid-1990s, morbidity and mortality among human immunodeficiency virus (HIV)-infected patients have decreased dramatically. Rates of opportunistic infections and AIDSdefining neoplasms registered a sharp decline, with a resulting drop in the number of related hospitalisations and deaths. 1, 2 Community-acquired pneumonia (CAP) is defined as an acute lower respiratory tract infection associated with new radiographic shadowing for which there is no other explanation and which is deemed to be community-acquired, as opposed to hospital-acquired or health care associated. 3, 4 HIV infection has been consistently described as a major risk factor for CAP, [5] [6] [7] [8] which is considered a stage 3 disease in the World Health Organization HIV staging classification 9 and an AIDS-defining illness by the American Centers for Disease Control and Prevention (CDC) when recurrent. 10 Despite a reported decline in incidence over the last two decades, [7] [8] 11 this condition remains frequent in this population, with its relative burden presently greater than before. [11] [12] [13] [14] In fact, CAP among HIVinfected patients has been found in some studies performed in high-income settings to be the most prevalent severe non-AIDS-defining infection and one of the most frequent reasons for hospital admission. 11, 12, 15, 16 Low CD4 cell counts, uncontrolled viral replication and absence of HAART have been associated with increased incidence. 6, 12, [14] [15] [16] Research has addressed this topic since the beginning of the HAART era, focusing on the course and outcome of CAP in HIV-positive patients. 5, 13, 15, [17] [18] [19] HIV infection is a known risk factor for bacteraemia, 5,19 but apparently not for higher mortality 5, 18, 20, 21 or time to clinical stability. 20, 21 Evidence on prediction of severity and resulting guidance on risk stratification and related management remains heterogeneous. 13, 15, 17, 18 In order to assess CAP severity on presentation and consequently guide therapeutic options, several prediction scales based on clinical and laboratorial criteria have been developed, which are nowadays widely used and endorsed by clinical societies worldwide. 3, 4, 22 The Pneumonia Severity Index (PSI), developed in the USA, uses a total of 20 variables, including clinical background and signs, and venous and arterial blood markers. 23 CURB-65, introduced by researchers from the UK, the Netherlands and New Zealand, uses a more elementary prediction rule based on four clinical and one laboratory parameter. 3 Clinicians in the Emergency Department (ED) are often faced with a great deal of uncertainty in applying general clinical prediction rules to HIV-positive patients and consequently deciding site-of-care. A few observational works on this field, which evaluated the applicability of PSI in this population, have consistently found that a high score correlates with a higher risk of mortality. 13, 17, 18 In one study designed to analyse the association between nasopharyngeal Pneumococcus density in South African HIV-positive patients with markers of disease severity and poor outcome, no correlation between CURB-65 scores and mortality was found. 24 Furthermore, it has not been clearly established whether HIV infection per se should be regarded as an additional independent prognostic marker.
In this work, we aimed to assess the prognostic importance of CURB-65 in the prediction of morbidity and mortality among HIV patients presenting with CAP. Our further goal was to determine if HIV seropositivity, greater immunosuppression, HAART use and lack of virological control act as additional independent prediction factors for worse outcomes.
Methods

Study design and setting
Using a retrospective cohort design, we studied all admissions occurring over the year 2010 in a tertiary teaching hospital centre in Lisbon, Portugal, which were classified by attending ED physicians as CAP.
Participants, measurements and outcomes
Hospital electronic diagnosis code registry, clinical notes, laboratory results and chest images were reviewed. HAART prescription, lymphocyte subset and viral load data were also assessed in Si.vida, a Portuguese national network platform where updated HIV-positive patients' data are stored.
All admitted adult patients (18 years or older) who met clinical and radiological criteria for pneumonia were primarily included. Exclusion criteria comprised respiratory infections which were in the course of admission found to be caused by mycobacteria or Pneumocystis, either by molecular, microbiological or histopathological methods. Patients hospitalised within 90 days prior to admission or meeting risk factors for health care-associated pneumonia 4 and patients with immunosuppression due to causes other than HIV infection (ongoing chemo-or radiotherapy, haematological malignancy, steroid use and asplenia) were also excluded.
Baseline variables included demographic data, comorbidities, HIV serostatus, lymphocyte subset count, CURB-65 score (confusion, urea level, respiratory rate, blood pressure and age >65 years) on ED admission. Patients were considered HIV-positive for the purpose of this study, either due to previously known chronic infection or as a result of a positive screen conducted in the course of admission. The primary outcome of interest was in-hospital mortality. Secondary outcomes were bacteraemia, ICU admission, orotracheal (OT) intubation and length of hospital stay.
The study was granted ethical approval by the Centre's Institutional Review Board.
Statistical analysis
The dataset was constructed using Excel (Microsoft Systems, Redmond, Washington, USA) and analysed using Stata 13.1 (Stata Statistical Software: Release 13. College Station, Texas, USA: StataCorp LP). A Chi square test and t-test were used to evaluate differences in baseline characteristics. Mantel-Haenszel stratification was used to adjust for age differences when comparing categorical outcomes in relation to HIV serostatus. Multivariate analysis was carried out using linear and logistic regression, in order to identify independent outcome predictors. A doublesided p value lower than 0.05 was considered significant. Associations are mainly expressed as odds ratios (OR) and adjusted odds ratios (aOR). Confidence intervals (CI) are shown for 95% levels.
Results
Over the study period, a total of 29,684 adult patients were admitted, 753 of whom for clinically and radiologically (chest radiograph or CT-scan)-confirmed pneumonia. After exclusion of 242 patients for healthcare-associated pneumonia and a further 199 for immunosuppression due to other causes, a total of 396 patients met the study inclusion criteria: 49 HIVpositive and 347 HIV-negative (Table 1) . HIV-positive patients were overall younger, predominantly men, with a higher proportion of smokers and lower prevalence of diabetes and heart failure.
Data were available for calculation of CURB-65 in 91.4% (n ¼ 362) of all patients. Mean CURB-65 scores were 1.3 points in HIV-positive and 2.2 points in HIV-negative patients (p < 0.0001; age adjusted p ¼ 0.44).
In-hospital mortality was 4.1% (n ¼ 2) for HIVpositive and 12.1% (n ¼ 42) for HIV-negative patients (age aOR 1.1 CI [0.2-6.3] p ¼ 0.90). Bacteraemia was documented in 8.9% (n ¼ 35) of all patients. Blood cultures drawn from HIV-positive patients were more likely to be positive (aOR 9.1 CI [3.1-27.2] p < 0.001). In all, 11.6% (n ¼ 46) were eventually admitted to an ICU and 9.6% (n ¼ 38) orotracheally intubated in the course of their admission. HIV-positivity did not result in significant differences either in ICU admission (aOR 3, 25 there was a significant trend for higher mortality both in HIV-positive and HIV-negative patients, whereas associations with ICU admission and OT intubation were significant only in either one of the serogroups ( Table 2 ). Receiver operating characteristics (ROC) curves and their respective areas under the curves (AUCs) are depicted in Figure 1 .
Lymphocyte subset determinations were available in 96% (n ¼ 47), viral load and HAART use in 98% (n ¼ 48) of all HIV-positive patients. The median CD4þT-lymphocyte cell count was 278 cells/mL (inter-quartile range 111-541). A majority (58%, n ¼ 28) was on HAART, 40% (n ¼ 20) having achieved viral load suppression in the latest determination. Linear regression showed a negative correlation between CD4 count and length of stay ( Figure 2) .
Adjusting for comorbidities and CURB-65 score values on multivariate logistic regression, HIVseropositivity did not independently predict mortality (aOR 1.1 CI [0.2-5.4] p ¼ 0.93), OT intubation (aOR 2.9 [0.9-9.2] p ¼ 0.08) or ICU admission (aOR 1.9 CI [0.7-5.4] p ¼ 0.23). It did however predict bacteraemia (aOR 7.1 CI [2.6-19.5] p < 0.001). Subgroup analyses within HIV-positive patients depicted in Table 3 , using HIV-negative patients as a comparator, showed that patients with CD4 counts below 200 cells/mL were at higher risk of ICU admission and OT intubation, whereas patients with counts above that value were not. No independent effect was seen for different subgroups of viral load suppression and HAART use regarding these outcomes. No subgroup was associated with different mortality and all were associated with higher blood culture positivity. 
Discussion
Our study suggests that CURB-65 scores on ED presentation are useful in discriminating mortality risk groups, regardless of HIV serostatus. HIV infection overall was associated with lower CURB-65 scores, higher rates of bacteraemia and similar CURB-65controlled clinical outcomes. However, the subgroup of HIV-positive patients with CD4 counts lower than 200 cells/mL had a higher chance of being admitted to an ICU and of being intubated. To our knowledge, this is the first work designed to study the CURB-65 score among HIV-positive patients and its findings suggest this score's prognostic performance is maintained in this population. Its reduced number of easily measurable variables makes its use very convenient in busy EDs and primary care centres. Compared to other scores such as PSI, its performance as a prediction rule has been widely validated, 26, 27 one large meta-analysis indicating it might be less sensitive but more specific. 26 HIV-positive patients in this study had significantly lower severity scores than their seronegative counterparts, similar to what was observed in the CAPO international cohort study. 20, 21 In our case, the difference can be explained by HIV-positive patients being younger, as age >65 years is a prognostic feature which contributes one point in the CURB-65 score, and there were no differences with respect to agecontrolled scores. This finding means other unaccounted factors guided clinicians in their decision to admit. One possible explanation could be that, compared to the overall population, HIV-positive patients have a higher prevalence of drug use and/or social vulnerability, making more individuals among them unreliable for outpatient therapy. Another potential reason could be that clinicians perceived HIV infection itself as a risk factor lowering the threshold for admission, as was proposed by Malinis et al. 21 regarding the CAPO study. Both factors could have confounded our study. The fact that there is a linear relation between CD4 cell count and length of stay and that a stratum-specific independent effect was observed for patients with CD4 cell counts <200 cells/mL regarding ICU admission and OT intubation suggests that this variable played a role in all these outcomes. Admission periods could have been protracted by a longer time to achieve clinical stability, but the higher risk of concomitant opportunistic diseases is also a consideration. More frequent ICU admission and OT intubation leads us to hypothesise that a greater impairment of cellular immunity put patients at risk of respiratory failure and/or severe sepsis. Accordingly, research has shown that CD4 cell depletion not only contributes to bloodstream invasion by Streptococcus pneumoniae but also to deregulated inflammatory response through impaired release of proinflammatory cytokines. 28 Stemming from different methodologies, there is disagreement in the association between lower CD4 cell counts and worse outcomes, including multilobar consolidation, longer time to clinical stability and increased mortality. Some studies have reported no impact of this marker on CAP outcome, 11, 17 whereas others have conversely found a significant impact on mortality, prompting authors to recommend admission of all patients in the <200 cells/mL subgroup. 13, 15, 29 Taking into account our results, in addition to CURB-65 scores, low CD4 cell counts seem to be independent predictive factors in the severity assessment of HIV-positive patients presenting with CAP. Both may thus be taken into consideration to aid clinical judgment when deciding site-of-care.
The major limitation of this study was the relatively small size of its HIV-positive cohort and the limited number of primary events in this population. Other limitations include its retrospective design and the fact that it was conducted in a single urban tertiary centre, which may limit its generalisability. Nevertheless, it is expected that our assumptions apply to other so-called high-income settings where HAART is widely accessible. Not all patients with unknown serostatus were tested for HIV, which could have resulted in underestimation of seropositivity and misclassification bias. Furthermore, patients presenting with CAP who were discharged from the ED were not included, a constraint of virtually all major works on this topic. 
